Long non-coding RNAs in prostate cancer: Functional roles and clinical implications

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Prostate cancer screening leads to overdiagnosis and overtreatment of indolent disease.
• Current biomarkers lack the necessary sensitivity and specificity for accurate diagnosis.
• Long noncoding RNAs (lncRNAs) are emerging as critical regulators in various cancers.

Purpose of the Study:

• To review current knowledge on lncRNA expression and mechanisms in prostate cancer.
• To highlight lncRNAs regulated by the androgen receptor in prostate cancer.
• To explore the potential of lncRNAs as diagnostic biomarkers and therapeutic targets.

Main Methods:

• Literature review of studies on lncRNAs in prostate cancer.
• Analysis of lncRNA expression patterns and regulatory mechanisms.
• Focus on androgen receptor-regulated lncRNAs and their functional roles.

Main Results:

• Aberrant lncRNA expression is frequently observed in prostate cancer.
• lncRNAs play significant roles in prostate cancer development and progression.
• Androgen receptor signaling influences the expression and function of specific lncRNAs.

Conclusions:

• lncRNAs represent promising novel biomarkers for improving prostate cancer diagnosis.
• Targeting specific lncRNAs may offer effective therapeutic strategies for prostate cancer.
• Further research into lncRNA mechanisms can guide clinical applications in prostate cancer management.